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Avoiding false-positive signals with nuclease-vulnerable molecular beacons in
single living cells
Abstract
There have been a growing number of studies where molecular beacons (MBs) are used to image RNA
expression in living cells; however, the ability to make accurate measurements can be hampered by the
generation of false-positive signals resulting from non-specific interactions and/or nuclease degradation.
In the present study, we found that such non-specific signals only arise in the nucleus of living cells. When
MBs are retained in the cytoplasmic compartment, by linking them to quantum dots (QDs), false-positive
signals are reduced to marginal levels. Consequently, MB–QD conjugates were used to measure the
expression of the endogenous proto-oncogene c-myc in MCF-7 breast cancer cells by quantifying the total
fluorescent signal emanating from individual cells. Upon the addition of tamoxifen, measurements of MB
fluorescence indicated a 71% reduction in c-myc expression, which correlated well with RT-PCR
measurements. Variations in MB fluorescence resulting from instrumental fluctuations were accounted
for by imaging fluorescent calibration standards on a daily basis. Further, it was established that
measurements of the total fluorescent signal were not sensitive to the focal plane. Overall, these results
provide evidence that accurate measurements of RNA levels can be made when MBs are retained in the
cytoplasm.
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ABSTRACT
There have been a growing number of studies where
molecular beacons (MBs) are used to image RNA
expression in living cells; however, the ability to
make accurate measurements can be hampered by
the generation of false-positive signals resulting
from non-specific interactions and/or nuclease
degradation. In the present study, we found that
such non-specific signals only arise in the nucleus
of living cells. When MBs are retained in the
cytoplasmic compartment, by linking them to quantum dots (QDs), false-positive signals are reduced to
marginal levels. Consequently, MB–QD conjugates
were used to measure the expression of the
endogenous proto-oncogene c-myc in MCF-7
breast cancer cells by quantifying the total fluorescent signal emanating from individual cells. Upon
the addition of tamoxifen, measurements of MB
fluorescence indicated a 71% reduction in c-myc
expression, which correlated well with RT-PCR
measurements. Variations in MB fluorescence
resulting from instrumental fluctuations were
accounted for by imaging fluorescent calibration
standards on a daily basis. Further, it was established that measurements of the total fluorescent
signal were not sensitive to the focal plane. Overall,
these results provide evidence that accurate
measurements of RNA levels can be made when
MBs are retained in the cytoplasm.

Variations in gene expression are commonly considered the
major determinant for dictating cell behavior. Accordingly,
methods to measure gene expression, such as reversetranscriptase (RT) PCR and DNA microarrays, have
proven to be invaluable with regard to understanding cell
regulatory processes and disease mechanisms. However,
these methods generally provide only the relative change in
gene expression for a population of cells. Under many

circumstances it is the aberrant behavior of only a few cells
or the stochasticity of RNA expression within a population
that may be of interest (1–6).
In order to gain a better understanding of cell-to-cell
variations in RNA expression, much eﬀort has recently
been devoted to developing methods for imaging RNA in
single living cells. Currently, the majority of live cell
imaging approaches utilize MBs, which are antisense
oligonucleotide probes labeled with a ‘reporter’ ﬂuorophore at one end and with a quencher at the other end (7).
In the absence of complementary nucleic acid targets,
the MBs assume a hairpin conformation, which brings the
ﬂuorophore and quencher into close proximity and creates
a low-ﬂuorescence or ‘dark’ state. Upon hybridization
with complementary targets the ﬂuorophore becomes
separated from the quencher and ﬂuorescence is restored.
The unique ability of MBs to convert target recognition
into a measurable ﬂuorescent signal has led to their use
in numerous applications ranging from monitoring
the distribution and transport of b-actin mRNAs in
motile ﬁbroblasts to monitoring viral growth in living
cells (8–18).
Despite their growing use, much debate remains over
whether MBs emit false-positive signals due to nonspeciﬁc interactions and/or degradation once introduced
into living cells. This possibility is fueled by several studies
where MBs were used to detect protein–DNA interactions
and the presence of nucleases in solution (19,20). Further,
there is evidence that MBs are quickly sequestered into
the nucleus via facilitated transport, again suggesting
undesirable protein–MB intracellular interactions in living
cells (8). In fact, one study reported that linear nuclease
resistant 20 -O-methyl probes performed just as well as
20 -O-methyl MBs in terms of RNA detection in living cells
(21). It was hypothesized that this was due to opening of
MBs by mechanisms other than hybridization.
In order to better understand whether MBs emit
false-positive signals once introduced into living cells, we
microinjected MBs that were not perfectly complementary
to any known endogenous RNA into MCF-7 breast
cancer cells. The total ﬂuorescent signal emanating from
single cells was then quantiﬁed over time. We observed a
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false-positive ﬂuorescent signal within the nucleus,
but not the cytoplasm. Once MBs were prevented from
gaining entry into the nucleus by conjugating them
to quantum dots (QDs), we no longer observed a nonspeciﬁc ﬂuorescent signal and were able to make sensitive
measurements of endogenous gene expression. Speciﬁcally,
we measured the expression of c-myc, an oncogene
implicated in a variety of breast cancers (22–26). We also
conducted experiments to evaluate the eﬀect of tamoxifen,
an anti-cancer drug, on the suppression of c-myc expression. Results were compared with quantitative RT-PCR.
METHODS
Molecular beacon design and synthesis
All oligonucleotide probes and targets were obtained
from Integrated DNA Technologies, Inc. (Coralville, IA,
USA). Antisense Fireﬂy luciferase (pGL3-Luc 235-252,
Promega) and antisense c-myc (564-581, GenBank
Accession V00568) MBs were labeled at the 50 -end with
a CAL FluorÕ Red 610 (Biosearch Technologies) ﬂuorophore, Cal610, and at the 30 -end with Iowa Black RQ
quencher, IBRQ. Anti-luciferase MBs were used as a
control sequence for these studies because this sequence
is not complementary to any endogenous RNA target
in MCF-7 cells. For studies requiring quantum-dot
conjugations, a biotin-dT group was incorporated
in the 30 -stem. The anti-luciferase MB employed
was
Cal610-GTCACCTCAGCGTAAGTGATGTCG
(bio-dT)GAC-IBRQ. The c-myc antisense MB employed
was
Cal610-GTCACGTGAAGCTAACGTTGAGGG
(bio-dT)GAC-IBRQ. Luciferase and c-myc target DNA
oligonucleotides were synthesized with the sequences,
GTCACGACATCACTTACGCTGAGTTT and GTC
ACCCTCAACGTTAGCTTCACTTT, respectively. An
antisense c-myc 20 -O-methyl RNA oligonucleotide was
synthesized with the sequence mGmUmGmAmAmGm
CmUmAmAmCmGmUmUmGmAmGmG.
Synthesis and spectral analysis of quantum dot-molecular
beacon conjugates
QD–MB conjugates (QD–MBs) were prepared using
biotinylated MBs and QD streptavidin conjugates
(QD800, Invitrogen). Speciﬁcally, 10 mM samples of the
MB were incubated with 1 mM QD streptavidin conjugates
at molar ratios of 5:1, 6:1, 10:1, 15:1, 20:1 and 100:1
in 50 mM sodium borate, 0.05% Tween, pH 8.3 at 48C
overnight. The speciﬁed molar ratios were obtained
by adjusting the volumes of the MB and QD sample
accordingly. QD–MBs were puriﬁed from unbound
MBs by gel chromatography (Superdex, GE Healthcare).
The concentration of the puriﬁed QD–MB was
determined by measuring the absorbance of QD800
(e405nm = 8 000 000 cm1M1) on a Cary100 spectrophotometer (Varian). Throughout the text the concentration
of the QD will be used to represent the QD–MB
concentration. QD–MB conjugates possess an average
diameter of 15–21 nm (27).
To ensure that the QD–MB samples were pure from
unbound MBs, an aliquot of the sample was centrifuged

on a Microcon YM-50 ﬁlter (50 kDa MW cutoﬀ,
Millipore). The eluent was then incubated in the presence
of complementary target and tested for the presence
of MBs by performing ﬂuorescence measurements
on a SPEX FluoroMax-3 spectroﬂuorometer (Horiba
Jobin Yvon). Speciﬁcally, the maximum ﬂuorescence
intensity of the hybridized MB (Cal610 Exc. = 590 nm,
Emm. = 610 nm) in the eluent was compared to that of
completely hybridized MBs in the stock QD–MB sample.
Typically, the ﬂuorescent emission contributed by
unbound MBs accounted for less than 2% of the
QD–MB emission at 610 nm.
The emission proﬁle of each QD–MB conjugate was
acquired on the FluoroMax-3 spectroﬂuorometer by
setting the excitation wavelength to 590 nm and recording
the emission from 600 to 825 nm. These experiments were
carried out in 50 mM sodium borate, 100 mM NaCl,
0.05% Tween, pH 8.3 (QMB Buﬀer) using 10 nM
QD–MBs in the presence or absence of 250 nM
complementary target. It was found that for MB:QD
molar ratios above 15:1 there was no signiﬁcant improvement in the maximum ﬂuorescence achieved in the
presence of excess target. Therefore, a MB:QD molar
ratio of 15:1 was used for all subsequent experiments.
Further hybridization experiments were carried out with
10 nM of the 15:1 QD–MBs in the presence of 10–250 nM
complementary target. The peak MB ﬂuorescence of this
sample reached a plateau at a target concentration of
120 nM. This suggests that all of the MBs were
hybridized at this target concentration. To estimate the
concentration of MBs that would be completely hybridized in the presence of 120 nM target, hybridization
experiments were conducted with 60, 90 or 120 nM MBs
in the presence of 10–250 nM complementary target. It
was found that the peak MB ﬂuorescence of the 90 nM
sample reached a plateau at a target concentration of
120 nM. This suggests that the QD–MB sample contains
90 nM MB. Since, the QD concentration is 10 nM, it is
estimated that there are 9 MBs per QD. Although this
measurement only provides an estimate of the MB-to-QD
ratio, this approach was preferred over spectrophotometric methods because the high absorbance of the QD at
the peak MB absorbance wavelength introduced variability between readings.
In order to evaluate the aﬀect of conjugating MBs to
QDs on the rate of hybridization, a 100 ml sample of 6 mM
luciferase target was added to 100 ml of 450 nM antisense
luciferase MBs or 100 ml of 50 nM QD–MB conjugates
(which is equivalent to 450 nM MBs). The samples were
mixed and ﬂuorescent measurements were taken immediately on a SPEX FluoroMax-3 spectroﬂuorometer
(Horiba Jobin Yvon) at 258C. All kinetics studies were
conducted in QMB buﬀer.
Fluorometric analysis of MB- and QD–MB-protein
interactions
MB and QD–MBs were incubated with single-stranded
binding (SSB) protein and bovine serum albumin
(BSA) to examine whether speciﬁc and non-speciﬁc
protein interactions could be responsible for generating
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false-positive signals. Speciﬁcally, 100 ml of 90 nM MBs
were mixed with 100 ml of 0.2 mg/ml BSA (2.99 mM) or
with 100 ml of 720 nM SSB protein in QMB buﬀer.
Control samples consisted of 100 ml of 90 nM MBs mixed
with 100 ml of 6 mM complementary target or 100 ml of
QMB buﬀer alone. Fluorescent measurements (excitation:
590 nm, emission: 610 nm) were taken on a SPEX
FluoroMax-3 spectroﬂuorometer (Horiba Jobin Yvon)
at 258C immediately following mixing. Fluorescence was
monitored over the course of 30 min at 1-min intervals.
End point measurements were taken at 24 h. MB
ﬂuorescence was normalized to the MB signal in the
presence of excess target. Analogous studies were carried
our using 10 nM QD–MBs, which is equivalent to 90 nM
MBs assuming a labeling ratio of nine MBs per QD. All
experiments were carried out in triplicates.
The ability of various nucleases to degrade MBs and
QD–MBs and generate false-positive signals was also
examined. Speciﬁcally, 100 ml of 90 nM MBs were mixed
with 100 ml of the 50 -exonuclease phosphodiesterase
I (2.25 mU) or with 100 ml of the 30 -exonuclease phosphodiesterase II (2.25 mU) in QMB Buﬀer. Similarly, 100 ml of
90 nM MBs were mixed with 80 ml of Mung Bean
endonuclease (2.24 mU) and 20 ml of 10 Mung Bean
Buﬀer (Promega). Finally, 100 ml of 90 nM MBs were
mixed with 80 ml of S1 endonuclease (2.24 mU) and 20 ml
of 10 S1 nuclease buﬀer (Promega). Control samples
consisted of 100 ml of 90 nM MBs mixed with 100 ml of
6 mM complementary target in each respective buﬀer or
mixed with 100 ml of the buﬀer alone. Fluorescent
measurements (excitation: 590 nm, emission: 610 nm)
were taken on a SPEX FluoroMax-3 spectroﬂuorometer
(Horiba Jobin Yvon) at 258C immediately following
mixing. Fluorescence was monitored over the course of
30 min at 1-min intervals. End point measurements were
taken at 24 h. MB ﬂuorescence was normalized to the MB
signal in the presence of excess target in the respective
buﬀer. Analogous studies were carried our using 10 nM
QD–MBs. All experiments were carried out in triplicates.
Cell culture
Estrogen-responsive MCF-7 cells (ATCC, Manassas, VA,
USA) were cultured in minimum essential medium (Eagle)
with 2 mM L-glutamine and Earle’s BSS adjusted to
contain 1.5 g/l sodium bicarbonate, 0.1 mM non-essential
amino acids, 1 mM sodium pyruvate and 10% fetal bovine
serum (FBS) in 5% CO2 at 378C. It should be noted that
estrogen was not removed from the FBS. Also, phenol red
was present. It has been reported that phenol red can
mimic the action of estradiol at a typical concentration of
30 mM (28). For all live cell-imaging experiments
(described subsequently), the MCF-7 cells were seeded
on a 60 mm petri dish at a conﬂuency of 10–30%.
In experiments where the eﬀect of tamoxifen on c-myc
expression was evaluated, MCF-7 cells were treated with
1 mM tamoxifen for 48 h prior to microinjection and
imaging of QD–MBs. All cell experiments were carried
out on cells passaged less than 20 times to ensure that they
do not acquire resistance to tamoxifen (29).

Fluorescence microscopy
All microscopy measurements were performed on an
Olympus IX 81 motorized inverted ﬂuorescence microscope equipped with a Sensicam (Cooke) monochrome
digital camera, an X-Cite 120 excitation source (EXFO)
and Sutter excitation and emission ﬁlter wheels.
Automated image acquisition was carried out using
IPLab (BD Biosciences). Images of Cal610 and QD800
were acquired using the ﬁlter sets (HQ560/55, HQ645/75,
Q595LP) and (e460spuv, D800/50, 475dcxru) (Chroma),
respectively. A LUC PLAN FLN 40 objective (NA 0.6)
was used for all cell imaging studies.
Water-in-oil bubble measurements
Fluorescent standards for comparing day-to-day ﬂuctuations in the ﬂuorescent intensity of the microscope set-up
were generated by microinjecting samples containing 100
nM MBs and 1 mM complementary oligonucleotide
targets in QMB buﬀer into paraﬃn oil. The MBs were
hybridized to their complementary targets for 24 h prior to
the ﬁrst day of microinjections. The same sample was used
for all ﬂuorescent measurements over the course of the
study. Fluorescent images of the water-in-oil bubbles were
acquired using the Cal610 ﬁlter set. These images were
subsequently analyzed with NIH Image J. Speciﬁcally,
a region of interest (ROI) was drawn around each bubble
and the total ﬂuorescent intensity was measured.
Similarly, the total ﬂuorescence intensity from an
equal sized ROI that was drawn around a ‘background’
region was also measured. The background subtracted
ﬂuorescence measurement for each bubble was then
calculated, FMB. Measuring the diameter of the bubble
and assuming a spherical geometry allowed the volume, V,
of each bubble to be calculated. The value FMB/V
was used to compare instrumental ﬂuctuations in ﬂuorescence intensity.
Water-in-oil microinjections studies were also conducted with 25 nM QD–MB conjugates (in the presence
and absence of 2.5 mM targets). When QDs were injected
into paraﬃn oil, there was no detectable signal in
the Cal610 channel indicating no spectral overlap between
the two ﬂuorescent reporters. This is in agreement with
measurements made on the spectroﬂuorometer. It should
also be noted that ﬂuorescence measurements were not
very sensitive to the focal plane in which the images were
acquired as long as an appropriate ROI encircling all of
the ﬂuorescence was utilized.
Single-cell fluorescence imaging and analysis
Microinjection. Microinjection of MCF-7 cells was carried out using a FemtoJet and Injectman NI 2
(Eppendorf) microinjection system ﬁtted with Femtotips
I (Eppendorf). Prior to use, Femtotips were treated with
Hexamethyldisilazane (Fluka) for 10 min, followed by
repeated washes in QMB buﬀer.
Image analysis. All image analyses were performed using
NIH Image J. Speciﬁcally, an ROI was drawn around
the injected cell and the total ﬂuorescent intensity within
the ROI was measured. In cells injected with QDs
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and QD–MB conjugates, the QD signal was used to help
locate the cell. Background measurements were acquired
by drawing ROIs outside the boundaries of the cell.
The background subtracted ﬂuorescent intensity from
each MB image, FMB, and each QD image, FQD, was then
calculated. All cells were analyzed as described here unless
otherwise noted.
Focal plane measurements. Samples containing 100 nM
QDs in QMB buﬀer were microinjected into MCF-7 cells.
The cells were brought into focus, and then images were
acquired from 21 mm below the focal plane to 15 mm
above the focal plane in increments of 3 mm. Total cellular
ﬂuorescence was then determined for each image as
described above.
Kinetic imaging. Samples containing 2.5 mM antisense
luciferase MBs in QMB Buﬀer were microinjected into
MCF-7 cells and imaged every 40 s for 46 min (n = 5).
Samples containing 10 mM antisense luciferase MBs in
QMB Buﬀer were microinjected into MCF-7 cells and
imaged every 10 s for 100 s (n = 8). Competitive inhibitor
studies were carried out by microinjecting MCF-7 cells
with samples containing both 2.5 mM antisense luciferase
MBs and 25 mM linear 20 -O-methyl RNAs targeting the
same sequence (n = 4). The images within each time series
were analyzed by drawing ROIs in the nucleus, cytoplasm
and just outside the cell border (i.e. background).
The same ROIs were used for all of the images in a
particular time series. The mean intensity within the
‘background’ ROI was subtracted from mean intensity of
the nucleus and cytoplasmic ROI and the resulting
intensity values were normalized by the maximum nuclear
ﬂuorescence and plotted versus time for comparison.
All kinetic measurements were performed at 258C.
Ratiometric imaging in living cells. Antisense luciferase
QD–MB conjugates at a concentration of 100 nM in QMB
Buﬀer were either hybridized to excess oligonucleotide
targets (2.5 mM) for 4 h or left unhybridized prior to
microinjection into MCF-7 cells. Cells that were injected
with QD–MBs in the absence of target (n = 6) were
imaged every 5 min for 25 min to examine whether any
noticeable degradation/non-speciﬁc interactions occurred,
as potentially indicated by an increase in MB ﬂuorescence.
Fluorescence image acquisition and analysis was then
performed as described above. Ratiometric measurements were calculated by simply dividing FMB by FQD.
Cells that were injected with QD–MBs in the presence of
target (n = 13) were imaged within 5 min following
microinjection.
Imaging c-myc RNA expression. A 25 nM c-myc antisense
QD–MB conjugates in QMB buﬀer were microinjected
into untreated and tamoxifen-treated MCF-7 cells.
Fluorescence image acquisition was then performed as
described above. Images acquired 10 min following
injection were used for analysis. Studies designed to
determine the speciﬁcity of MB hybridization were carried
out by co-injecting MCF-7 cells with 25 nM c-myc
antisense QD–MB conjugates in the presence of excess

linear 20 -O-methyl RNAs targeting the same sequence.
Statistics comparing FMB of each experiment were
performed using a two-tailed Student’s t-test. Signiﬁcant
diﬀerence was taken at P < 0.01.
Quantitative RT-PCR
RT-PCR standards. c-myc RNA standards were created
by performing in vitro transcription driven by a
T7-promoter proceeding the coding sequence of c-myc
cDNA (Origene) using the RiboMAXTM large-scale RNA
production system as per manufacturer’s protocol.
The resulting RNA was puriﬁed using lithium chloride
precipitation followed by ethanol precipitation. Brieﬂy, an
appropriate volume of LiCl was added into the transcription-mix to achieve a ﬁnal concentration of 1.5 M.
The mixture was then incubated on ice, spun at 20 000 g
in 48C, and the supernatant was discarded. The pellet was
further washed with ice-cold 70% ethanol, dried in a
speedvac apparatus and re-suspended in ice-cold nucleasefree water (Ambion). Following additional washes with
ice-cold 100% ethanol in the presence of 0.3M sodium
acetate and 70% ethanol, the puriﬁed RNA was subsequently dried in a speedvac apparatus and then
re-suspended in 140 ml of nuclease-free water (Ambion).
The concentration was determined by measuring the
absorbance at OD260 on a Cary100 spectrophotometer
(Varian) and serial dilutions were prepared for RT-PCR.
Quantitative RT-PCR. Cytoplasmic RNA from MCF-7
cells was isolated using the HighPure RNA isolation kit
(Roche) and subsequently reversed-transcribed to cDNA
using High Capacity cDNA reverse transcriptase kit
(Applied Biosystems) as per manufacturer’s protocol.
Standard curves for the absolute quantiﬁcation of c-myc
RNA were generated by ﬁrst adding known amounts of
serially diluted c-myc RNA to the cell lysates of MCF-7
cells, immediately prior to RNA puriﬁcation. Samples
containing no additional c-myc RNA were used to generate
a baseline measurement following RT-PCR. Quantitative
RT-PCR was performed on ABI PRISM 7300 Sequence
detection system using FAM-labeled TaqmanÕ primer sets
for c-myc and b-actin, and the TaqmanÕ universal PCR
Master Mix (Applied Biosystems) according to the
manufacturer’s protocol.
RESULTS AND DISCUSSION
Molecular beacons elicit a non-specific signal in the
nucleus of living cells
To investigate whether MBs composed of a nucleasevulnerable DNA backbone elicited a false-positive signal
in living cells, we microinjected MBs that were not
perfectly complementary to any known endogenous
RNA into MCF-7 breast cancer cells. It was hypothesized
that these MBs would remain quenched unless opened due
to non-speciﬁc interactions and/or nuclease degradation.
Consequently, any increase in ﬂuorescence would indicate
a false-positive event.
Immediately following the cytoplasmic microinjection
of MBs, there was a clear increase in ﬂuorescence in the
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nucleus, while there was no detectable change in
ﬂuorescence in the cytoplasm (Figure 1a). The ﬂuorescent
signal in the cytoplasm remained extremely faint and was
barely distinguishable from the background. The rate of
increase in ﬂuorescence observed in the nucleus varied
with injected dose, with lower concentrations of MBs
taking longer before the ﬂuorescent signal in the nucleus
reached a plateau. Speciﬁcally, when MBs at a concentration of 10 mM were injected into the cytoplasm, the
ﬂuorescent signal within the nucleus typically reached a
plateau between 1 and 2 min; however, when cells were
injected with 2.5 mM of MBs the ﬂuorescent signal did not
plateau for 40–50 min (Figure 1b). This diﬀerence may
largely be due to a faster diﬀusion into the nucleus,
although a higher concentration of MBs may also occupy
a higher percentage of the protein machinery, and thus
expedite the process of active transport as well.

In order to determine whether the increase in ﬂuorescence in the nucleus was in response to undesirable MB
hybridization or due to non-speciﬁc protein interactions
(or nuclease degradation), live cell competitive inhibition
studies were performed. Speciﬁcally, an excess of linear
20 -O-methyl RNAs with the same targeting-sequence as
the MBs were co-injected with MBs into MCF-7 breast
cancer cells. It was expected that if the MB signal were due
to target hybridization, then the 20 -O-methyl RNAs would
compete for the same binding sites and reduce/eliminate
the ﬂuorescent signal. Despite injections of 10-fold excess
20 -O-methyl RNAs, we continued to observe an increase in
MB ﬂuorescence in the nucleus; however, the rate of
increase was slightly reduced (Figure 1b). Presumably,
a slower increase in ﬂuorescence is due to the DNA MBs
and the 20 -O-methyl RNAs utilizing some of the
same machinery for active transport into the nucleus.
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Figure 1. Nuclear localization of MBs. (a) Fluorescent microscopy images of MCF-7 cells microinjected with either 2.5 mM or 10 mM samples of
MBs. The MBs are not perfectly complimentary to any known endogenous RNA in MCF-7 cells. An increase in ﬂuorescence was observed in the
nucleus shortly after injection in all cells analyzed. (b) The mean ﬂuorescent intensity measured in the nucleus (ﬁlled diamonds) and cytoplasm (ﬁlled
circles) was plotted as a function time. The ﬂuorescent signal increased in the nucleus but not the cytoplasm. The rate of increase depended on the
injected concentration of MBs. Higher concentrations of MBs led to a more rapid nuclear localization. When MBs were co-injected with 20 -O-methyl
RNAs with the same targeting-sequence into MCF-7 cells, there was still an increase in nuclear ﬂuorescence (open diamonds); however, the rate of
increase in ﬂuorescence was slightly slower. The ﬂuorescent signal within the cytoplasm remained low (open circles).
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Figure 3. Hybridization kinetics. The rate of hybridization of free MBs
(solid line) to complementary target and QD–MBs (dashed line) to
complementary target were compared. Normalized ﬂuorescent intensity
is plotted versus time.
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Figure 2. Schematic and emission spectrum of QD–MB conjugates.
(a) Schematic of MB-QD conjugates in the presence and absence of
target RNA. (b) The emission spectrum for 10 nM QMBs (Cal610
reporter, Iowa Black RQ quencher, and a QD800 quantum dot) was
recorded in the absence and presence of excess complementary
oligonucleotide targets. The addition of complementary target led to
a large increase in MB ﬂuorescence; however, the QD ﬂuorescence
remained unchanged. This labeling ratio (prior to puriﬁcation) was 6
MBs per QD for the QD–MB emission spectrum shown.

Nonetheless, these observations suggest that the MB
signal in the nucleus is likely to be non-speciﬁc, involving
mechanisms other than hybridization.
MBs retained in the cytoplasm do not elicit false-positive
signals
As noted earlier, when MBs with no known intracellular
RNA target were injected into MCF-7 breast cancer cells
only very faint ﬂuorescent signals were observed in the
cytoplasm. To investigate whether this was due to
complete sequestration of the MBs into the nucleus or
because MBs remained in a quenched hairpin conformation in the cytoplasm, we attached MBs to QDs so they
would not be able to pass through the nuclear pores
(Figure 2a).
QDs were chosen over large non-karyophilic proteins
such as streptavidin as a means of inhibiting entry into the
nucleus because QDs also provide a bright and stable
ﬂuorescent signal that can be used for tracking MB
localization. Further, the QD ﬂuorescence allows for
accurate ratiometric measurements since the QD signal
remains unquenched regardless of the conformation of the
probe (Figure 2b). Ratiometric measurements are helpful

in removing experimental variability in single-cell kinetic
studies because while changes in ﬂuorescent intensity due
to instrumental ﬂuctuations will directly alter the intensity
of the MB and QD signal individually, their ratio will
remain unchanged. Of course, one concern with using
QDs is that their large size might interfere with MB-target
hybridization; however, comparison of the kinetics of
in vitro hybridization of free MBs and MB-QD conjugates
indicated that the QDs had relatively little aﬀect on
hybridization (Figure 3). This result is in agreement
with previous studies where DNA attached to submicron
latex particles exhibited rate constants similar (0.2 to
1) to those of unconjugated DNA in homogeneous
solutions (30). Since the diﬀusion boundary layer is so
small on micro- and nanoparticles, slower hybridization
kinetics would have likely meant that the QD–MB probe
was reaction-rate limited (31). Perhaps, the separation
between the MBs on each QD, likely due to the spacing of
biotin binding domains, helps limit any type of steric
interference during QD–MB-target hybridization.
It has recently been reported that conjugation of MBs
to QDs could result in ﬂuorescence resonance energy
transfer (FRET) (27). Indeed some FRET was observed
with the QD–MB conjugates reported here. Speciﬁcally,
the ﬂuorescence of unhybridized MBs was quenched by
70% upon conjugation to QDs; however, upon the
addition of excess complementary target the conjugated
MBs only exhibited a 34% reduction in peak ﬂuorescence
compared with an equimolar amount of unconjugated
MBs. These measurements assume a labeling ratio of nine
MBs to each QD. The larger extent of quenching of
MB-QD conjugates in the hairpin conformation leads to
an improvement in signal-to-background (S:B = 93)
compared with unconjugated MBs (S:B = 43). In contrast
to the MB ﬂuorescence, the QD signal is increased by
2.3% upon conjugation to MBs.
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Figure 4. Single cell measurements of MB and QD ﬂuorescence. (a) QD–MBs in the absence of target or pre-hybridized to target we microinjected
into MCF-7 cells. QD–MBs in the absence of target exhibited a bright ﬂuorescent signal in the QD image but no signal was visible in the MB image.
QD–MBs prehybridized to target exhibited a bright ﬂuorescent signal in both the QD and MB images. In all images, the QD–MBs were only
observed in the cytoplasmic compartment. (b) Single-cell measurements of total integrated MB ﬂuorescence divided by total integrated QD
ﬂuorescence, following microinjection of QD–MBs in the absence of target (n = 19) and QD–MBs prehybridized to target (n = 13).

2.15  0.29, which indicates an average intracellular
signal-to-background ratio (i.e. [FMB/FQD]With Target/
[FMB/FQD]No Target) of 23:1 (Figure 4b). The diﬀerence
between intracellular and solution measurements of
signal-to-background is likely due to lower signal-to-noise
in live cell studies. Nonetheless, these ﬁndings provide
evidence that the MBs remain in their quenched hairpin
conformation when limited to the cytoplasmic
compartment.

1.0

FMB / FQD

0.8
0.6
0.4

MB-protein interactions and MB degradation

0.2
0
0

5

10

15

20

25

Time (minutes)
Figure 5. Temporal measurements of QD–MB ﬂuorescence in single
living cells. QD–MBs that are not perfectly complementary to any
known endogenous RNA were microinjected into MCF-7 breast cancer
cells (n = 6). The ratio of total integrated MB ﬂuorescence divided by
total integrated QD ﬂuorescence was monitored over time. No increase
in MB ﬂuorescence was observed for 25 min.

When non-targeted QD–MB conjugates were microinjected into living cells, the QD–MBs were localized
entirely in the cytoplasmic compartment and no MB
ﬂuorescence was observed in the cell immediately after
injection (Figure 4a), although image analysis did indicate
an MB signal slightly above the background in all of the
images. The average single-cell ﬂuorescent ratio FMB/FQD
was calculated to be 0.094  0.061. No further increase in
signal was observed for at least the next 20 min (Figure 5),
indicating the absence of false-positive signals.
When QD–MB conjugates were pre-hybridized to
complementary oligonucleotide targets prior to microinjection into MCF-7 cells, a bright ﬂuorescent signal in
the cell cytoplasm was visible in both the MB and QD
images. The ﬂuorescent ratio FMB/FQD was found to be

To gain insight into the cause of the false-positive signal
observed in the nucleus following the microinjection of
MBs into living cells and to determine the eﬀect of
conjugating MBs to QDs on these interactions, a
ﬂuorometric analysis of MBs and QD–MBs in the
presence of various proteins and nucleuses was conducted.
It was found that non-speciﬁc interactions with BSA did
not result in a substantial increase in ﬂuorescent emission
for either the MBs or QD–MBs (Figure 6a); however, SSB
protein did cause a signiﬁcant increase in ﬂuorescence.
Speciﬁcally, the MB ﬂuorescence increased to 17.9  0.2%
of the signal elicited by a completely hybridized MB, while
the QD–MB ﬂuorescence increased to 4.9  0.2% of the
signal elicited by a completely hybridized QD–MB. The
lesser eﬀect of SSBs on QD–MB ﬂuorescence suggests that
steric interference may limit SSB-MB binding when the
MBs are conjugated to QDs.
Previous studies have shown that when MBs (250 nM)
are incubated in the presence of saturating concentrations
of SSB (529 nM), the MB signal can increase to more than
90% of the signal elicited by a completely hybridized MB
(19). It is hypothesized that the smaller increase observed
in our experiments is due to incomplete binding at the
lower concentrations of MB (45 nM) and SSB (360 nM)
tested.
When MBs and QD–MBs were incubated with phosphodiesterase I (50 -exonuclease) and phosphodiesterase II
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Figure 6. Fluorometric analysis of MB- and QD–MB-protein interactions and endonuclease degradation. (a) MBs and QD–MBs were incubated with
molar excess of complementary target, BSA and SSB (n = 3 each) and the peak ﬂuorescent intensity of the MB was measured. SSB generated a falsepositive signal upon binding to MBs and QD–MBs, although the increase in signal was much less pronounced with QD–MBs. (b) Incubation of MBs
and QD–MBs with S1 endonucleases resulted in a signiﬁcant increase in ﬂuorescence. Both probes were degraded at similar rates. Mung Bean
nuclease was also capable of degrading MBs and QD–MBs but to a much lesser extent than S1 nucleases. All ﬂuorescent measurements were
normalized to the signal elicited by MBs and QD–MBs, respectively, in the presence of saturating concentrations of complementary target.

(30 -endonuclease), only a small increase in MB and
QD–MB ﬂuorescence was observed over a period of
30 min (Supplementary Figure 1). Although a slightly
faster rate of increase in ﬂuorescence was observed with
unconjugated MBs, the diﬀerence is negligible. It appears
that the reporter ﬂuorophore and quencher at the 50 - and
30 -end respectively limited exonuclease activity for both
MBs and QD–MBs. In contrast to exonucleases, MBs and
QD–MBs were both highly susceptible to degradation by
S1 endonucleases (Figure 6b). The ﬂuorescent signal of
both probes increased to 60% of their maximum with
30 min. Mung Bean endonucleases, which are known to
cleave hairpin loops, also degraded both MBs and
QD–MBs, but to a much lesser extent than S1 nucleases.
The rate of degradation was similar for MBs and
QD–MBs in the presence of endonucleases.
Based on our ﬁndings, it appears that both singlestranded DNA binding proteins and endonucleases could
be responsible for generating false-positive signals in the
nucleus following the microinjection of MBs into living
cells. Although SSB proteins and nucleases are also
present in the cytoplasm, previous reports have demonstrated that there are fewer DNA–protein interactions in
the cytoplasm compared with the nucleus and that
nuclease activity in the cytoplasm is low (32,33). These
diﬀerences could help explain why MBs only elicited
detectable false-positive signals in the nucleus. Our
ﬁndings also suggest that the QD–MB signal may
remain quenched following microinjection into living
cells not only because of cytoplasmic localization but
also due to fewer interactions with SSB proteins.
Measurements of instrumental fluctuations in fluorescence
In general, when performing live cell studies with MBs it
is expected that the total MB ﬂuorescence within single
cells would correlate directly with the copy number of

target RNA. However, when comparing ﬂuorescent
images of cells that were acquired at diﬀerent time
points or on diﬀerent days, the total ﬂuorescent signal
may not only reﬂect the extent of MB hybridization but
also instrumental variability. For example, the intensity of
MB ﬂuorescence would scale directly with ﬂuctuations in
the intensity of the excitation light source. Although the
eﬀects of instrumental variability could potentially be
removed with ratiometric imaging, this approach is only
eﬀective when monitoring ﬂuorescence within a single cell.
When mRNA levels in diﬀerent cells are compared,
ratiometric measurements would also be dependent on
the eﬃciency of probe delivery, i.e. the number of
QD–MBs delivered into a cell. For example, if twice the
number of QD–MB conjugates are injected into a cell,
then the ﬂuorescent ratio would be reduced to half because
the number of QDs would be doubled but the number of
hybridized MBs (i.e. the number of RNA targets) would
remain the same.
Since tightly controlling the number of probes delivered
into a cell is very diﬃcult, even with microinjection where
cell volume, morphology, and the actual microinjection tip
being used could all aﬀect delivery, ratiometric imaging is
unlikely to provide accurate measurements of gene
expression. Therefore, we chose to image gene expression
by directly quantifying the MB signal emitted by single
cells. In order to reduce the impact of instrumental
variability we developed a simple method to calibrate the
ﬂuorescent microscope each day or even multiple times a
day so that absolute measurements of MB ﬂuorescence
could be acquired and the recorded values could be
adjusted according to any instrumental ﬂuctuations that
were measured. It should be noted that absolute measurements of MB ﬂuorescence are not as sensitive as
ratiometric measurements to the injected dose of MBs
because the ﬂuorescent signal of the unhybridized MBs
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is quenched. Only at high concentrations (above 2 mM)
was it possible to visualize the background ﬂuorescence of
quenched MBs above the noise.
The microscope calibration methodology involved
injecting known concentrations of pre-hybridized MBs
into paraﬃn oil, which results in the formation of
spherical water-in-oil bubbles (Supplementary Figure 2
inset). With this approach, each bubble serves as a wellcharacterized ﬂuorescent standard that can be imaged
directly on the microscope. It was hypothesized that any
changes that were observed in MB ﬂuorescence would
correspond to instrumental ﬂuctuations. Although MBs
were utilized here, they can easily be replaced with any
ﬂuorescent molecule.
Since the total ﬂuorescence of each bubble increases
linearly with volume, which can vary from bubble to
bubble, ﬂuorescent intensity measurements were compared only after being normalized by the respective bubble
volume (FMB/V). These measurements were conducted
multiple times a day for 1 week and whenever semiquantitative measurements of ﬂuorescence were being
performed. We found that within any given day there were
only very small ﬂuctuations in the ﬂuorescence intensity of
the microscope, i.e an SD of less than 3% in ﬂuorescent
intensity measurements (Supplementary Figure 2); however, between days ﬂuorescence intensity measurements
diﬀered by as much a 28%. This suggests that each time
the light source is ignited it may have a slightly diﬀerent
intensity. Daily measurements of instrumental ﬂuctuations
in ﬂuorescence intensity were used to adjust measurements
of MB and QD ﬂuorescence accordingly.
Focal plane has marginal effect on measurements of total
cellular fluorescence
In addition to instrumental ﬂuctuations, it may be
speculated that another potential source of error when
quantifying and comparing the ﬂuorescence of multiple
cells is any diﬀerence in the focal plane. When ﬂuorescently labeled cells are observed under a microscope, there
are clear changes in the peak ﬂuorescent signal as the cells
are brought in and out of focus. Cells that are in focus
exhibit a very bright clear signal, while cells that are out of
focus exhibit a fainter ﬂuorescent signal that is diﬀuse over
a much larger area. Despite these visual diﬀerences, when
using wide-ﬁeld ﬂuorescent microscopy the number of
ﬂuorophores being excited and the number of photons
being detected were hypothesized to be the same,
assuming no major losses in light due to absorption
between the cell and the objective. To validate that total
cellular ﬂuorescence is indeed independent of focal plane,
QD–MB conjugates were microinjected into MCF-7 cells
and images were acquired from 15 mm below the focal plan
of the cell to 15 mm above the focal plane in increments of
3 mm (Supplementary Figure 3a). The total QD ﬂuorescence in each image was then measured, making sure to
include all of the ﬂuorescent signal within the ROIs that
were drawn around each cell. This often required drawing
regions of interest well outside the cell itself. As shown in
Supplementary Figure 3b, there appeared to be only a
small loss in signal as the focal plane moved through

the cells. In fact, the percent diﬀerence between the total
ﬂuorescent signal measured at the focal plane and the
total ﬂuorescent signal measured 15 mm above or below
the focal plane was less than 3.3%. Therefore, it
was concluded that quantitative measurements of
QD and MB ﬂuorescence are not dependent on the focal
plane.
QD–MB conjugates allow for imaging of endogenous c-myc
expression
In order to evaluate whether QD–MB conjugates could be
used to sensitively detect endogenous gene expression
across a population of MCF-7 breast cancer cells,
microinjection experiments were performed using antisense c-myc QD–MB conjugates. A ﬂuorescent signal was
detectable in the cytoplasm of all the microinjected cells.
Interestingly, the diﬀerence in total integrated ﬂuorescence
between the faintest and brightest cell was more than
5-fold (Figure 7). It is hypothesized that this observed
variation at least partly reﬂects the stochasticity in gene
expression, which has been shown to play a pivotal role in
governing cellular fates and disease evolution (1–6).
However, instrumental noise also is surely a contributing
factor.
Two negative control experiments were conducted to
examine whether the measured ﬂuorescent signal truly
reﬂected MB hybridization or false-positive events. The
ﬁrst negative control consisted of injecting MBs with no
known intracellular RNA target into MCF-7 cells. Image
analysis of MB ﬂuorescence revealed signals that were
statistically lower (P < 0.01) than antisense c-myc signals.
In general, the MB signal could not even be detected
visually, and thus the QD ﬂuorescence was necessary to
identify the location of the cell. The second negative
control consisted of competitively inhibiting MB hybridization with excess linear 20 -O-methyl RNAs targeting the
same sequence. Again, a semi-quantitative analysis of MB
ﬂuorescence revealed a signal that was statistically lower
than the antisense c-myc signals (P < 0.01). These results
suggest that QD–MB conjugates can be used for the
speciﬁc and sensitive detection of endogenous RNA in
single living cells.
When MCF-7 cells were treated with tamoxifen, the
average measure of total cellular ﬂuorescence was 71%
lower than in untreated MCF-7 cells. This is in agreement
with previous reports, which found that tamoxifen caused
a signiﬁcant reduction in the global expression of c-myc
(23,34,35). Interestingly, while the majority of the cells
exhibited an extremely faint ﬂuorescent signal similar
to the negative controls, there were a small number of
cells that exhibited a ﬂuorescent signal similar to
untreated cells. It is hypothesized that these outliers may
represent a small percentage of cells that are resistant to
tamoxifen.
When Quantitative RT-PCR was carried out on MCF-7
cells with and without tamoxifen treatment, we observed
a 74  2% decrease in c-myc expression following
tamoxifen treatment, which agrees well with the MB
data (Figure 8). These results support the use of MBs that
are restricted to the cytoplasmic compartment for the

10 Nucleic Acids Research, 2007

(a) 25

(b) 40
35
Percent of Cells

Percent of Cells

20
15
10

30
25
20
15
10

5

5
0

0
0

1

2

3

4

5

6

7

8

9

10

0

Total Integrated Fluorescence (AU)

2

3

4

5

6

7

8

9

10

9

10

Total Integrated Fluorescence (AU)

(c) 40

(d) 30

35

25

30

Percent of Cells

Percent of Cells

1

25
20
15

20
15
10

10
5

5
0

0
0

1

2

3

4

5

6

7

8

9

10

Total Integrated Fluorescence (AU)

0

1

2

3

4

5

6

7

8

Total Integrated Fluorescence (AU)

Figure 7. Measurements of MB ﬂuorescence in MCF-7 cells. (a), MCF-7 cells were microinjected with antisense c-myc QD–MBs (n = 55) and the
total integrated ﬂuorescence within each cell in the MB images were determined. All measurements were normalized by the total ﬂuorescence
measured in the brightest cell and then multiplied by 10. (b) Total integrated MB ﬂuorescence from MCF-7 cells co-microinjected with QD–MBs and
20 -O-methyl RNAs with the same targeting-sequence (n = 27). (c) Total integrated MB ﬂuorescence from MCF-7 cells microinjected with MBs that
are not perfectly complementary to any known endogenous RNA (n = 15). (d) Total integrated MB ﬂuorescence from MCF-7 cells microinjected
with antisense c-myc QD–MBs following treatment of cells with tamoxifen (n = 40).
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Figure 8. Eﬀect of tamoxifen on c-myc expression. RT-PCR and
QD–MBs both indicate a 70–75% downregulation in c-myc expression
following treatment of MCF-7 cells with tamoxifen. The error bars
represent the standard error.

semi-quantitative measurement of endogenous gene
expression. Quantitative RT-PCR revealed that the
average copy number of c-myc mRNA per MCF-7 cell
was 2907  289 for untreated cells and 747  101 for
tamoxifen-treated cells. While this data provides insight
into the sensitivity of QD–MB conjugates, it is important
to note that absolute measurements of copy number are
highly sensitive to RNA handling and methodology
(36,37). For comparison, another report indicated a
copy number of 8000 c-myc transcripts in MCF-7 cells
(38,39).
In summary, we demonstrate that MBs only elicit a
non-speciﬁc signal in the nucleus. When MBs are retained
in the cytoplasmic compartment, by conjugation to QDs,
false-positive signals are reduced to marginal levels.
Variations in MB ﬂuorescence resulting from instrumental
ﬂuctuations can be accounted for by imaging waterin-oil ﬂuorescent calibration standards on a daily basis.
As a result, QD–MB conjugates can be used as an eﬀective
tool for imaging the expression of speciﬁc mRNAs in
single living cells.
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